bisphosphonates

Seven Mid-Atlantic States Move To Adopt Restrictions On NSAIDS, Joint Injections

More than 60 racing industry stakeholders representing regulators, horsemen and racetrack operators from the seven states that comprise the Mid-Atlantic region (Delaware, Maryland, New Jersey, New York, Pennsylvania, Virginia, and West Virginia), 11 jurisdictions, and 17 racetracks convened at Delaware Park Oct. 2 to take the next steps toward implementation of the Mid-Atlantic Strategic Plan […]

Continue reading
RMTC Approves Model Rules For Bisphosphonates Regulation

At its August 19 meeting at Del Mar Turf Club in Del Mar, California, the Racing Medication and Testing Consortium (RMTC) board approved a model rule for the regulation of bisphosphonates as well as further regulations and stacking prohibitions for non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular (IA) injections. The proposed Model Rule for the regulation […]

Continue reading
Keeneland Encourages Endoscopic Videos For September Yearling Sale

Keeneland is encouraging consignors and veterinarians who are participating in its September Yearling Sale, to be held Sept. 9-22, to use the capabilities in the repository to upload and view endoscopic videos of horses scheduled to sell. Keeneland supports the recent announcement by the Consignors and Commercial Breeders Association that it has endorsed the American […]

Continue reading
The Friday Show Presented By The MATCH Series: Testing, Testing?

This week, one of the more well-known Thoroughbred horse racing consignors, Stonestreet Farm, announced the move that it would make blood testing available six months prior to auctions, specifically to catch any use of anabolic steroids and off-label use of bisphosphonates. In this edition of The Friday Show, Scott Jagow and Ray Paulick discuss that […]

Continue reading
Stonestreet Farm Launches Yearling Warranty For Bisphosphonates And Anabolic Steroids

Leading commercial breeder Stonestreet Farm has announced the development of an innovative blood sampling, testing, and secure storage protocol in partnership with The University of Kentucky’s Gluck Equine Research Center. The program was developed in response to reports of off-label bisphosphonate use in growing horses. Combined with newly available post-sale testing offered by auction houses, […]

Continue reading
CHRB Approves Medication Restrictions At Golden Gate, Sonoma, Humboldt

The California Horse Racing Board conducted its regular meeting Thursday, June 20, at the Alameda County Fairgrounds. Chairman Chuck Winner presided. Vice Chair Madeline Auerbach and Commissioners Dennis Alfieri and Fred Maas also were in attendance. The audio of this entire Board meeting is available on the CHRB Website (www.chrb.ca.gov) under the Webcast link. In […]

Continue reading
AAEP Foundation, RMTC, Grayson-Jockey Club Foundation Issue Call For Bisphosphonate Research Proposals

Three organizations dedicated to the improvement of horse health today announced a call for research proposals to investigate bisphosphonate administration in racehorses and in young racing prospects intended for sale at public auction. The initiative by the Racing Medication and Testing Consortium (RMTC), the Grayson-Jockey Club Research Foundation and the American Association of Equine Practitioners […]

Continue reading
In The Fight Against Off-Label Bisphosphonate Use, Is Sale Company Testing The Next Step?

As the racing industry continues to struggle in the fight against off-label bisphosphonate use, some wonder whether testing by sales companies could be the next step. In a meeting of the Kentucky Horse Racing Commission this week, equine medical director Dr. Mary Scollay told commissioners current tests will only pick up bisphosphonates between 30 and […]

Continue reading
PR Special Keeneland April Sale: Explaining Bisphosphonates, Diagnosing Poor Performance

The Paulick Report is once again on the sales grounds with a special print publication for the Keeneland April sale of 2-year-olds in training and horses of racing age. In this edition of the PR Special, Natalie Voss looks into the hot issue of bisphosphonates, going into detail about the drugs and one of the […]

Continue reading
Drug Maker Issues Statement Regarding Bisphosphonates: Unscrupulous Use ‘Morally Reprehensible’

Dechra Veterinary Products prides itself as a global leader in the ethical and responsible use of pharmaceuticals. The health of the horse is our first and foremost priority, and a driving force in our product development, commercialization and ongoing research efforts. We are passionate advocates of equine welfare and our people, science and products deliver […]

Continue reading
Twitter Twitter
Paulick Report on Instagram